SPARKees Projects
The SPARK-Bordeaux program was founded in 2018. Since 2018, more than 18 projects have been supported with mentoring, advice and an extensive network.
SPARK Active Projects
Track 2024
Hypoxia-schemiaencephalopathy– Anne Karine Bouzier Sore (CRMSB UMR5536)
Lactate as a novel therapeutic approach for neonates suffering from hypoxia-ischemia encephalopathy
Post Traumatic Stress Disorder– Jean Michel Revest (INSERM U1034)
Developping a BiomarkerDiagnosis for PTSD
Neuropathic Pain – Pascal Fossat (CNRS UMR5293)
Developement of a new drug candidate to treat neuropathic pain
Williams Beuren Syndrom– Susanna Pietropaolo (UMR 5287, INCIA)
Big calcium-dependent potassium channels as a novel therapeutic target for WBS
Hearing Loss– Raphael Devillard (U1026 Biotis)
Cochlear-gene therapy by laser-assisted drug delivery
Liver Cancer – Fréderic Saltel (UMR 1312)
Prediction of first line treatment response in patients with advanced hepatocellular carcinoma by proteomic profiling
Small Vessel Disease– Claire Peghaire (INSERM U1034)
Drug repurposing strategy targeting the NRF2 pathway for the treatment of cerebral small vessel disease
Autoimmunedisease– Patrick Blanco / Gael Champier (UMR/CNRS 5164, Immunoconcept)
New hope to fight ANCA Vasculitis and Systemic Lupus Erythematosus / From Lab to regulatory
Track 2023
|
PI |
Project Title |
|
SPARK-Mentors |
|
Rodrigue Rossignol |
First treatment to Costello and Noonan syndrome (RASopathies) – ANK0121 |
Pharma |
Vassilios Kaltasos, Anne Charlotte Reix, Jean Luc Chagnaud, |
|
Claire Leibler |
New treatmentstrategy in AAV |
Pharma |
Damien Dessis, Jean Luc Chagnaud |
SPARK Alumni Projects
| TITLE |
DESCRIPTION |
PROJECT OVERVIEW |
CONTACT |
| BORDSFORD |
Board expert screening for dysimmunity |
Frédéric Villega | |
| VIBI |
Innovative matrix for a vascularized and innervated bone engineered implant |
Bruno Paiva Dos Santos | |
| DBS |
Automatic segmentation of pre-operative MRI and prediction of optimal deep brain stimulation targets: an AI approach |
Nejib Zemzemi | |
| Diag RCC |
|||
| Retinet |
Prévenir la survenue d'une maladie cécitante et incurable appelée la dégénérescence maculaire liée à l'âge, la DMLA. |
Start-up : MacuTest |
Soufiane Ajana |
| Furin |
Furin and Covid-19 : Structure, Function and Chemoinformatic Analisis of Representative Active Site Inhibitors |
Majib Khatib | |